Welcome to OP-Virtual – An online interactive forum to discuss the most important topics and trends impacting drug development and manufacturing outsourcing, and working with CDMOs.
Throughout the year, our Chief Editor, Louis Garguilo, brings together industry experts to discuss how sponsor companies can tackle some of today's biggest challenges in managing your CDMOs. Our audience gets to ask and have answered their questions during the presentation. Each OP-Virtual session is archived, and can be accessed at any time by registered site users.
A NEW DECADE OF OUTSOURCING: WHAT CAN WE EXPECT?
Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.
Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."
MANAGING YOUR CDMOS - ADVICE FROM PROFESSIONALS WHO HAVE BEEN ON BOTH SIDES OF OUTSOURCING
At our second OP-Virtual, Outsourced Pharma Chief Editor Louis Garguilo invited professionals who have had careers at both CDMOs and biotechs to give us advice, and some best practices, regarding what they’ve learned having been on both sides of the outsourcing equation. Here are excerpts from the opening comments of our speakers.